AIM: Because Dutch health care organisations did want to establish well-defined diabetes shared care groups, we investigated the organisation of insulin therapy in general practice in the Netherlands and assessed factors that were associated with providing insulin therapy in type 2 diabetes (DM2) patients. METHODS: Questionnaire to half of the Dutch general practitioners (GPs) (n=3848). We compared GPs who both start insulin treatment and monitor the dosages with those who always refer patients requiring insulin therapy or only monitor insulin dosages. RESULTS: Total response was 42% (n=1621). 67% of the GPs start insulin therapy in patients with DM2, especially male GPs and those above the age of 40, as well as GPs working in a health centre and those working together with a practice nurse. GPs working in urban regions less often start insulin. The most often mentioned barriers for starting and/or monitoring insulin therapy are lack of knowledge of insulin therapy, lack of time and insufficient financial incentives. CONCLUSION: This nation-wide overview shows that insulin therapy is no longer a secondary care based activity. However, there is still need to enlarge the practice staff and to overcome the perceived skills deficit.
AIM: Because Dutch health care organisations did want to establish well-defined diabetes shared care groups, we investigated the organisation of insulin therapy in general practice in the Netherlands and assessed factors that were associated with providing insulin therapy in type 2 diabetes (DM2) patients. METHODS: Questionnaire to half of the Dutch general practitioners (GPs) (n=3848). We compared GPs who both start insulin treatment and monitor the dosages with those who always refer patients requiring insulin therapy or only monitor insulin dosages. RESULTS: Total response was 42% (n=1621). 67% of the GPs start insulin therapy in patients with DM2, especially male GPs and those above the age of 40, as well as GPs working in a health centre and those working together with a practice nurse. GPs working in urban regions less often start insulin. The most often mentioned barriers for starting and/or monitoring insulin therapy are lack of knowledge of insulin therapy, lack of time and insufficient financial incentives. CONCLUSION: This nation-wide overview shows that insulin therapy is no longer a secondary care based activity. However, there is still need to enlarge the practice staff and to overcome the perceived skills deficit.
Authors: M Dankers; M J E van den Berk-Bulsink; M van Dalfsen-Slingerland; H J M G Nelissen-Vrancken; A K Mantel-Teeuwisse; L van Dijk Journal: BMC Prim Care Date: 2022-06-13
Authors: Elizabeth Marrett; Qiaoyi Zhang; Claudia Kanitscheider; Michael J Davies; Larry Radican; Mark N Feinglos Journal: Diabetes Ther Date: 2012-06-15 Impact factor: 2.945
Authors: Jo-Anne Manski-Nankervis; Irene Blackberry; Doris Young; David O'Neal; Elizabeth Patterson; John Furler Journal: BMC Health Serv Res Date: 2014-11-01 Impact factor: 2.655
Authors: Patricia Sunaert; Sara Willems; Luc Feyen; Hilde Bastiaens; Jan De Maeseneer; Lut Jenkins; Frank Nobels; Emmanuel Samyn; Marie Vandekerckhove; Johan Wens; An De Sutter Journal: BMC Fam Pract Date: 2014-08-21 Impact factor: 2.497